/PRNewswire/ Lyfebulb, a patient-empowerment platform that bridges patients with industry to support user-driven innovation, education and connectivity, is.
J.P. Morgan Asset Management announced the launch of a new life sciences private equity team, Life Sciences Private Capital. The new team will invest in both early and growth stage healthcare companies across multiple strategies aligned to specific market opportunities, with a focus on novel therapeutics and technologies in several target areas.
The new team will invest in early and growth-stage healthcare companies aligned to specific market opportunities with a focus on novel therapeutics and technologies.